Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eton Pharmaceutcials Inc 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010 USA

www.etonpharma.com Employees: 31 P: 847-787-7361

Sector:

Medical

Description:

Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.

Key Statistics

Overview:

Market Capitalization, $K 407,902
Enterprise Value, $K 422,772
Shares Outstanding, K 26,818
Float, K 22,519
% Float 83.97%
Short Interest, K 2,028
Short Float 7.56%
Days to Cover 7.88
Short Volume Ratio 0.53
% of Insider Shareholders 16.03%
% of Institutional Shareholders 27.86%

Financials:

Annual Sales, $ 39,010 K
Annual Net Income, $ -3,820 K
Last Quarter Sales, $ 22,460 K
Last Quarter Net Income, $ -1,930 K
EBIT, $ -2,680 K
EBITDA, $ -420 K

Growth:

1-Year Return -7.06%
3-Year Return 338.33%
5-Year Return 56.97%
5-Year Revenue Growth 3,963.54%
5-Year Earnings Growth 85.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/06/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -0.12
EPS Growth vs. Prev Qtr 30.00%
EPS Growth vs. Prev Year -450.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ETON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 14.59
Price/Earnings to Growth N/A
Return-on-Equity % -11.32%
Return-on-Assets % -2.96%
Profit Margin % -9.79%
Debt/Equity 1.31
Price/Sales 5.79
Price/Cash Flow N/A
Price/Book 17.17
Book Value/Share 0.86
Interest Coverage -0.83
60-Month Beta 1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar